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DNA damage is one of the most common insults that challenge all cells. To cope, an
elaborate molecular and cellular response has evolved to sense, respond to and correct
the damage. This allows the maintenance of DNA ﬁdelity essential for normal cell viability
and the prevention of genomic instability that can lead to tumor formation. In the context of
oocytes, the impact of DNA damage is not one of tumor formation but of the maintenance
of fertility. Mammalian oocytes are particularly vulnerable to DNA damage because
physiologically they may lie dormant in the ovary for many years (>40 in humans) until
they receive the stimulus to grow and acquire the competence to become fertilized. The
implication of this is that in some organisms, such as humans, oocytes face the danger of
cumulative genetic damage for decades.Thus, the ability to detect and repair DNA damage
is essential to maintain the supply of oocytes necessary for reproduction.Therefore, failure
to confront DNA damage in oocytes could cause serious anomalies in the embryo that may
be propagated in the form of mutations to the next generation allowing the appearance of
hereditary disease. Despite the potential impact of DNA damage on reproductive capacity
and genetic ﬁdelity of embryos, the mechanisms available to the oocyte for monitoring and
repairing such insults have remained largely unexplored until recently. Here, we review the
different aspects of the response to DNA damage in mammalian oocytes. Speciﬁcally,
we address the oocyte DNA damage response from embryonic life to adulthood and
throughout oocyte development.
Keywords: oocytes, DNA damage response, meiotic recombination, p63, DNA damage checkpoint, meiosis,
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THE DNA DAMAGE RESPONSE
Cells respond to DNA damage created in the form of single strand
breaks (SSBs) or double strandbreaks (DSBs) by arresting their cell
cycle to allow time for the damage to be repaired. Therefore, the
DNA damage response (DDR) involves cell cycle arrest through
the activation of DNA damage checkpoints (DDCs) and DNA
damage repairmechanisms. TheDDR sequence of events is tightly
coordinated so that cell cycle arrest is lifted as soon as the damage
has been repaired. When the extent of damage does not allow
full repair, programed cell death mechanisms become active in
order to remove, through apoptosis, the permanently damaged
cells (Bartek and Lukas, 2007; Ciccia and Elledge, 2010).
Eukaryotic cells activate DDR mechanisms primarily at the
G1/S-phase transition and the G2/M-phase transition. In both cell
cycle phases, DSB or SSB establish a DDC by triggering the activa-
tion of the master kinases ATM (ataxia telangiectasia mutated)
and ATR (ataxia telangiectasia and Rad3-related), respectively
(Reinhardt and Yaffe, 2009; Smith et al., 2010). At G1, the major
downstream effector of the ATM/ATR kinases is the transcrip-
tion factor p53, also known as “the guardian of the genome”
(Figure 1; Kastan and Lim, 2000; Bartek et al., 2007). When acti-
vated, p53 blocks the transcription of cell cycle regulators that
normally induce the G1/S-phase transition, such as cyclin E, while
driving the transcription of factors that block theG1/S-phase tran-
sition, such as the cyclin-dependent kinase (CDK) inhibitor, p21
(Rocha et al., 2003; Mirzayans et al., 2012). p53 is also the pri-
mary inducer of apoptotic mechanisms following DNA damage
(Fridman and Lowe, 2003; Meulmeester and Jochemsen, 2008).
At G2, establishment of the DDC and subsequent M-phase
entry inhibition requires the ATM/ATR-dependent activation of
checkpoint kinases, Chk1 and Chk2 (Figure 2; Bartek and Lukas,
2007; Smith et al., 2010). Normally, entry intoM-phase is obtained
by the activation of the universal M-phase regulator, cyclin B-
CDK1 (Doree and Hunt, 2002; Lindqvist et al., 2009). Cyclin
B-CDK1activation requires cyclinB synthesis and the activationof
Cdc25 phosphatases which lift CDK1 inhibitory phosphorylations
established by CDK1 inhibitors such as Wee1 and Myt1 kinases
(Aressy and Ducommun, 2008; Potapova et al., 2009). Following
DNA damage at G2, Chk1/Chk2 kinases cause the inhibition of
cyclin B-CDK1 activation by disrupting the action of Cdc25 either
through facilitating SCF (Skp, Cullin, F-box) ligase-dependent
degradation, as in the case of Cdc25A or through inhibitory phos-
phorylation (Cdc25B, Cdc25C; Mailand et al., 2000; Busino et al.,
2003; Ferguson et al., 2005; Boutros et al., 2007).
During the DDC-mediated arrest, DNA damage is repaired by
a number of different mechanisms depending on the nature of
the damage. Single strand damage is repaired by three main repair
pathways: base excision repair (BER), nucleotide excision repair
(NER), and mismatch repair (MMR). Two are the major mecha-
nisms involved in DSB repair, namely homologous recombination
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FIGURE 1 | Schematic representation of the major steps of the G1
DNA damage checkpoint. Double strand breaks (DSB) and single strand
breaks (SSB) cause the activation of the master DNA damage checkpoint
kinases ATM and ATR, respectively. ATM phosphorylates and activates the
downstream effector checkpoint kinases Chk1 and Chk2, while ATR
activates Chk1. ATM/ATR and the checkpoint kinases activate the
transcription factor p53. p53 drives the transcription of the
cyclin-dependent kinase (CDK) inhibitor p21. p21 binds and inhibits CDKs
responsible for progression into S-phase, such as Cyclin E-CDK2. As a
result, the cell cycle arrests at G1.When the DNA damage cannot be
repaired, p53 drives the cell to apoptosis through the transcription of
pro-apoptotic genes, such as PAX, PUMA, and NOXA. It must be noted that
this ﬁgure is an oversimpliﬁed representation of the pathways enabled in
response to DNA damage at G1 phase. : activating phosphate.
(HR) and non-homologous end joining (NHEJ; Aguilera and
Gomez-Gonzalez, 2008; Cohn and D’Andrea, 2008).
PROPHASE ARREST
The oocyte is a unique cell that differs signiﬁcantly both from
somatic cells but also from the male germ cells in respect to its cell
cycle, its functions and its purpose. A unique characteristic of the
oocyte, not seen in any other cell type, is prophase arrest.
The mechanisms regulating meiotic prophase arrest and
resumption of meiosis resemble the establishment of the somatic
cell G2 DDC and checkpoint recovery, respectively (Figures 2 and
3; Bassermann et al., 2008; Solc et al., 2010). The major common
element in both systems is the alteration of cyclin B-CDK1 activ-
ity, predominantly through the action of CDK1 activators and
inhibitors (Bassermann et al., 2008; Solc et al., 2010).
FIGURE 2 | Schematic representation of the major steps of the G2
DNA damage checkpoint. At S/G2 phase, DSBs and SSBs activate ATM
and ATR, respectively. As a consequence, checkpoint kinases Chk1 and
Chk2 become activated. Chk1 and Chk2 can directly phosphorylate and
activateWee1 or Myt1 kinases.Wee1/Myt1 impose inhibitory
phosphorylations on the M-phase kinase Cyclin B-CDK1 in order to block
M-phase entry. At the same time, the checkpoint kinases directly
phosphorylate and inhibit Cdc25 phosphatases. Unlike the inhibitory
phosphorylations of Cdc25B and Cdc25C, checkpoint kinase-dependent
phosphorylation of Cdc25A allows its recognition by the SCF/βTrCP ligase.
Subsequent ubiquitination of Cdc25A renders the phosphatase a substrate
for the proteasome leading to its degradation. As a result of their inhibition,
the Cdc25 phosphatases cannot remove the inhibitory phosphate from
CDK1. Consequently, the cell cycle arrests at G2 due to inhibition of CDK1
activation. The activating CDK1 phosphorylation is introduced by
CDK-activating kinases but is masked by theWee1/Myt1 inhibitory
phosphorylations. : activating phosphate. : inhibiting phosphate.
Before the endof gestationoocytes becomearrested at thedicty-
ate stage of the meiotic prophase (Rodrigues et al., 2008). During
prophase arrest in oocytes, cyclin B-CDK1 remains inactive due
to the maintenance of high levels of cAMP within the oocyte and
the subsequent sustained activation of protein kinase A (PKA;
Figure 3;Mehlmann et al., 2002; Schmitt andNebreda,2002). PKA
phosphorylates and inactivates the Cdc25 isoform Cdc25B which
is responsible for cyclin B-CDK1 activation in oocytes (Lincoln
et al., 2002; Pirino et al., 2009; Oh et al., 2010). Furthermore, PKA
phosphorylates and activates the CDK1 inhibitor Wee1B which
is the oocyte-speciﬁc Wee1 isoform (Han et al., 2005; Oh et al.,
2010). Following the rise in the levels of luteinizing hormone
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FIGURE 3 | Regulation of prophase arrest and resumption of meiosis.
(A) Regulation of prophase arrest. During the arrested state, a signaling
pathway that is established in response to the interactions of the oocyte
with its neighboring granulosa cells leads to the accumulation of cAMP in
the oocyte. cAMP causes the phosphorylation of protein kinase A (PKA).
Similarly to Chk1 and Chk2 during the G2 DNA damage checkpoint, PKA in
prophase-arrested oocytes phosphorylates and activatesWee1 kinase and
speciﬁcally theWee1 isoformWee1B. Furthermore, PKA phosphorylates
and inhibits Cdc25B phosphatase. As a result, Cyclin B-CDK1 remains
inactive and the oocyte arrested in meiotic prophase. (B) Resumption of
meiosis. During the estrus cycle, the surge of the luteinizing hormone (LH)
drives a signaling cascade that results in the decline of cAMP levels in the
oocyte. This leads to PKA inactivation, ending the PKA-dependent
phosphorylation ofWee1B and Cdc25B. Just as in M-phase entry in
somatic cells, Wee1B becomes inactive and Cdc25B is activated in order to
remove the inhibitory phosphates from CDK1. In response to Cyclin
B-CDK1 activation, the oocyte enters the ﬁrst meiotic M-phase.
: activating phosphate. : inhibiting phosphate.
(LH), during the estrus cycle, cAMP levels drop and PKA becomes
inactive allowing CDC25B activation and the subsequent cyclin
B-CDK1 activation leading to entry into the ﬁrst meiotic M-phase
(MI; Lincoln et al., 2002; Marangos and Carroll, 2004; Solc et al.,
2010).
Most of the information we possess regarding the mammalian
oocyte DDR involves prophase arrest.
MEIOTIC RECOMBINATION CHECKPOINTS
In mammalian oocytes, DNA breaks are ﬁrst identiﬁed during
meiotic recombination. Meiotic recombination is a process that
takes place before birth from the leptotene to the pachytene stage
of meiotic prophase and involves the natural formation of DSBs.
Since meiotic recombination processes are extensively reviewed
elsewhere (Lydall et al., 1996; Roeder and Bailis, 2000; Burgoyne
et al., 2009; Martinez-Perez and Colaiacovo, 2009; Kurahashi et al.,
2012) we will limit our analysis to a very general overview of the
major aspects of the recombination-induced DDR in mammalian
oocytes.
At the start of meiotic prophase (embryonic day 13–18.5 post-
coitus in female mice), homologous chromosomes pair along
their full length in a process called synapsis (Roeder, 1997; Liv-
era et al., 2008; Martinez-Perez and Colaiacovo, 2009). During
synapsis and following the initiation of homolog pairing, DNA
DSBs appear within the chromosomes. These DSBs allow DNA
exchange between homologous non-sister chromatids through
genetic recombination (McDougall et al., 2005; Burgoyne et al.,
2009). Recombination leads to the formation of natural bridges,
called chiasmata, which hold the homologous chromosomes
together until MI allowing their attachment from the opposite
poles of the MI spindle and their alignment at the metaphase I
plate (McDougall et al., 2005; Burgoyne et al., 2009). Therefore,
formation of chiasmata during meiotic recombination ensures
the correct segregation of homologous chromosomes during the
ﬁrst meiotic division. Meiotic recombination dysfunctions can
cause damaged genomes and the formation of aneuploid gametes
(Burgoyne et al., 2009; Yanowitz, 2010; Kurahashi et al., 2012).
Therefore, meiotic cells have developed checkpoint mechanisms
around the pachytene stage of meiotic prophase in order to ensure
the integrity and the completion of recombination (Lydall et al.,
1996; Roeder and Bailis, 2000). In mammals, the activation of the
recombination pachytene checkpoint when meiotic cells do not
complete HR in time leads to cell death through apoptosis (Lydall
et al., 1996; Roeder and Bailis, 2000). In oocytes, dysfunction of
factors involved in the recombination process leads to apoptosis
at the perinatal period (Pittman et al., 1998; Baudat et al., 2000; Di
et al., 2005).
In meiotic recombination, it is well established that Spo11
is the main factor to promote the formation of DSBs (Bau-
dat et al., 2000; Di et al., 2005). However, recent ﬁndings have
shown that homolog pairing is completely abolished in Spo11−/−
spermatocytes suggesting that Spo11 is also required for the DSB-
independent initiation of synapsis (Boateng et al., 2013). Absence
of the Spo11-dependent homolog pairing and DSB formation
leads to oocyte apoptosis during early follicular development, soon
after birth (Baudat et al., 2000; Di et al., 2005). Similar observa-
tions are made in mice lacking Spo11-associated proteins, such
as Mei4 (Kumar et al., 2010). In Spo11 null mice, the oocytes
that survive and acquire the competence to enter M-phase can-
not segregate their homologous chromosomes properly due to the
absence of chiasmata and remain arrested atMI (Cole et al., 2010).
Other factors, such as ATM and DMC1 are responsible for
rejoining the DNA strands (Pittman et al., 1998; Yoshida et al.,
1998; Roeder and Bailis, 2000; Di et al., 2005). Besides its role
in DDC establishment, ATM is a crucial component of HR repair
mechanisms (Smith et al., 2010). The importance of these proteins
in DNA strand rejoining is shown by the fact that the absence of
DMC1 or ATM leads to programed cell death in prophase oocytes
and DMC1 null and ATM null mice are infertile as are Spo11
null mice (Pittman et al., 1998; Yoshida et al., 1998; Baudat et al.,
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2000; Di et al., 2005). However, in the case of DMC1 and ATM,
the oocytes do not reach the stage of becoming enclosed in fol-
licles and degenerate, through apoptosis earlier than Spo11 null
oocytes (Pittman et al., 1998; Yoshida et al., 1998; Baudat et al.,
2000; Di et al., 2005). Furthermore, in DMC1-Spo11 and ATM-
Spo11 double mutants the oocyte reserve depletion phenotype
resembles the one seen in Spo11 null mice, which leads to the
conclusion that the Spo11 mutation is epistatic to the DMC1
and ATM mutations (Di et al., 2005). These results indicate that,
unlike Spo11 mutants, the different phenotype of the DMC1 and
ATM mutants is possibly the result of persistent, unrepaired DNA
damage.
Besides ATM, other traditional ATM-dependent DDR factors
are activated at the sites of meiotic recombination-induced DNA
damage in order to amplify the DSB signal, such as ATR kinase,
BRCA1 and the phosphorylated form of the nucleosomal histone
H2AX (γH2AX; Xu et al., 2003; Burgoyne et al., 2007). However,
in the absence of DSBs, ATR, BRCA1, and γH2AX are recruited on
unsynapsed homologous chromosomes in order to impose their
transcriptional silencing (Turner et al., 2005; Mahadevaiah et al.,
2008; Burgoyne et al., 2009). If synapsis is not successful, transcrip-
tional silencing can lead to apoptosis if important active genes
cease to function (Burgoyne et al., 2009; Kurahashi et al., 2012).
This DSB-independent process allows the elimination of oocytes
with unsynapsed chromosomes and could explain the Spo11−/−
oocyte death phenotype.
Therefore, there appear to be two checkpoint responses
to recombination defects in oocytes: a DNA DSB-dependent
response triggered by unrepaired DSBs and a DNA DSB-
independent response triggered by the absence of synapsis. In
both cases, the activation of the checkpoint will lead to apoptosis.
However, it is not yet determined howunrepaired, recombination-
induced DSBs would trigger apoptosis in oocytes.
p63-DEPENDENT PATHWAY
In mammalian oocytes, DSBs induced as a consequence of
genotoxic stress trigger the activation of a TAp63-dependent
mechanism which drives affected oocytes to apoptosis (Suh et al.,
2006; Kerr et al., 2012a).
TAp63 is an isoform of p63 which belongs to the p53 fam-
ily of transcription factors. This protein family includes three
transcription factors, namely p53, p63, and p73 (Levine et al.,
2011). Besides being important for the activation of DDR mech-
anisms, mainly cell cycle arrest and apoptosis of damaged cells,
these factors also possess a wide range of other functions includ-
ing their involvement in maternal reproductive efﬁciency. p53 has
been shown to regulate embryo implantation (Hu et al., 2007).
TAp73, a p73 isoform, is involved in the M-phase spindle assem-
bly checkpoint and mice lacking TAp73 are infertile. In female
TAp73−/− mice, infertility is due to chromosome missegregation
leading to chromosomal abnormalities in the dividing oocyte and
pre-implantation stage embryo (Tomasini et al., 2008; Levine et al.,
2011). TAp63, a p63 isoform, is the only p53 family member iden-
tiﬁed so far to participate in the oocyte DDR. Although, TAp63 is
not expressed in the male germ cells, a newly identiﬁed hominidae
isoform,GTAp63, seems to possessDDR functions inmales (Beyer
et al., 2011; Amelio et al., 2012).
TAp63 is found in the nucleus of oocytes enclosed in pri-
mordial, primary and early pre-antral follicles (Figure 4) but is
completely lost in the more mature, antral, follicles (Suh et al.,
2006). TAp63 expression begins at embryonic day 18.5 up to
adulthood (Suh et al., 2006; Livera et al., 2008). p63 has also
been found in human embryonic stage oocytes (Livera et al.,
2008). Nevertheless, TAp63 seems to be completely dispensable
for oogenesis and the loss of TAp63 does not affect the oocyte
reserve. The importance of TAp63 for the oocyte DDR was ﬁrst
identiﬁed in TAp63 null mice. In wild type and p53−/− ani-
mals, ionizing radiation causes the complete deterioration and
loss of primordial follicles, while the larger pre-antral follicles
remain unaffected. However, the oocytes in primordial follicles
of the TAp63 null mice were resistant to irradiation and cell
death (Suh et al., 2006). These experiments showed that TAp63
induces cell death in primordial follicle oocytes with damaged
DNAand that this function is not sharedwithp53. Itmust benoted
that p63 seems to be only involved in DNA damage-dependent
apoptosis since the rate of physiological embryonic oocyte death
in p63−/− ovaries is not different from wild type ovaries
(Livera et al., 2008).
It has been proposed that, following DNA damage in oocytes,
TAp63 becomes activated through phosphorylation by c-Abl tyro-
sine kinase (Gonﬂoni et al., 2009). Gonﬂoni and colleagues have
shown that c-Abl inhibition by imatinib or GNF-2 protected
oocytes from apoptosis in response to cisplatin-induced DNA
damage (Gonﬂoni et al., 2009; Maiani et al., 2012). p63 phospho-
rylation drives resting inactive dimmers to form tetramers which
possess the ability to bind DNA and activate the transcription
machinery (Deutsch et al., 2011). The possible mechanism for
Tap63 activation could involve the DNA damage-induced activa-
tion of the stress kinase c-JunN-terminal kinase (JNK). In somatic
cells, JNK phosphorylates the 14-3-3 proteins which under phys-
iological conditions sequester c-Abl in the cytoplasm (Yoshida
et al., 2005). 14-3-3 phosphorylation releases c-Abl to become
transported into the nucleus in order to phosphorylate and acti-
vate Tap63. However, there has been some skepticism regarding
c-Abl involvement because pharmacological agents, such as ima-
tinib have occasionally been unable to inhibit oocyte apoptosis
(Kerr et al., 2012b; Maiani et al., 2012). At the moment, it appears
that the controversy surrounding c-Abl would only be resolved
conclusively by genetically removing c-Abl from the female germ
line.
Another very important question, however, is: which are the
transcriptional targets of Tap63 that trigger apoptosis? Recently,
two such targets have been identiﬁed in mouse oocytes, namely
PUMA andNOXA (Kerr et al., 2012c). Both proteins belong to the
pro-apoptotic arm of the Bcl-2 family and they have been known
to inhibit pro-survival Bcl-2 proteins and promote the function
of BAX and BAK, two major pro-apoptotic Bcl-2 family mem-
bers, which in turn enable the mitochondria-induced apoptosis
mechanisms (Chipuk and Green, 2008; Youle and Strasser, 2008).
TAp63 enables the transcription of both PUMA and NOXA in
mouse primordial follicle oocytes. In addition, PUMA−/− mice
and especially the double mutants PUMA−/− NOXA−/− mice,
do not lose their primordial follicle pool in response to genotoxic
stress (Kerr et al., 2012c). Therefore, TAp63-dependent PUMAand
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NOXA expression is most possibly responsible for driving oocyte
apoptosis following DNA damage.
The knock-out mouse models of TAp63, PUMA and NOXA
have shown that inhibition of the TAp63 pathway can rescue the
primordial follicle oocyte pool from apoptosis following DNA
damage. These observations could open novel medical options
in order to sustain the fertility of women undergoing cancer ther-
apy. It is well known that chemotherapy and radiation therapy
for treating cancer leads to depletion of the ovarian oocyte reserve
and leads to premature ovarian failure (POF) andhence premature
menopause (Maltaris et al., 2007). Therefore, possible treatments
that are based on the inhibition of the TAp63 pathway could allow
the preservationof the oocyte pool following cancer therapy. How-
ever, is it safe to allow damaged oocytes to survive following cancer
treatment? It would be expected that these oocytes carry signiﬁ-
cant damage that could be transferred to their offspring. However,
an exciting result refutes these concerns: although wild type mice
lose their primordial follicle reserve and become infertile following
genotoxic stress, PUMA−/− and PUMA−/− NOXA−/− female
mice exposed to ionizing radiation have viable, healthy, and fertile
offspring at the same rate as wild type mice not exposed to DNA
damage (Kerr et al., 2012c). This ﬁnding suggests that during their
long prophase arrest, oocytes possess the ability to repair DNA
damage efﬁciently. Although more work needs to be done before
treatments are obtained, these observations bring hope to cancer
patients facing infertility.
The fact that genotoxic stress does not prevent the preserva-
tion of healthy oocytes when the TAp63 pathway is inhibited,
raises an interesting question: why is a TAp63-dependent apop-
totic pathway needed in oocytes? The answer might lie slightly
before TAp63 expression, at the time of meiotic recombination.
Quite conveniently, TAp63 is expressed following the physiological
recombination-induced DSB repair. Immunoﬂuorescence experi-
ments show thatγH2AX foci representing recombination-induced
DSBs do not co-exist with TAp63. In mouse oocytes, γH2AX
staining disappears by E18.5 by which time TAp63 becomes appar-
ent (Livera et al., 2008). In this way, oocytes undergoing meiotic
recombination are not in danger of apoptosis. However, as previ-
ously discussed, sustained DSBs during recombination, trigger the
establishment of oocyte deathmechanisms. The activationof these
processes during and following the pachytene stage of prophase
coincides with the appearance of TAp63. Therefore, TAp63 may
FIGURE 4 | Mammalian oocyte DNA damage checkpoints in relation to
follicular and oocyte development. In most mammals, only a few hundred
oocytes reach the competence to become fertilized. At the beginning of
oogenesis, mitotically dividing oogonia proliferate to form a population of a
few million. Most become destroyed through apoptosis while all the
remaining enter meiosis before birth. These oocytes become surrounded by a
single layer of epithelial cells forming primordial follicles. Following birth,
ovarian follicles from this primordial pool mature spontaneously into primary
and secondary follicles. During this stage of follicular maturation the oocyte
grows in size and becomes surrounded by more layers of proliferating
follicular cells which are in turn surrounded by layers of theca cells. However,
these pre-antral follicles never reach full maturity and soon become atretic
and deteriorate. At puberty and following the rise in the levels of the follicle
stimulating hormone (FSH), during every estrus cycle, a small number of
follicles mature beyond the pre-antral stage forming an antrum (antral follicle).
From these follicles only a few reach the pre-ovulatory stage (Rodrigues et al.,
2008). In the mouse, sustained unrepaired recombination-induced DSBs
trigger oocyte apoptosis following the pachytene stage of meiotic prophase
during embryonic life. These oocytes rarely survive to form primordial follicles
around the time of birth. Genotoxic stress activates TAp63-dependent
apoptosis at the diplotene stage of prophase.TAp63-induced apoptosis affects
oocytes from the primordial stage of follicle development up to the pre-antral
stage (primary and secondary follicles). Apoptosis does not appear in later
stages of oocyte development. From the large pre-antral to the pre-ovulatory
follicular stage, the oocyte remains in prophase arrest which may allow any
inﬂicted DNA damage to be repaired. The fully grown oocyte which
possesses the competence to resume meiosis and enter the ﬁrst meiotic
M-phase (MI) cannot establish cell cycle arrest checkpoints in response to
DNA damage. It is possible that such checkpoints may be activated during
meiotic M-phase. E, embryonic day; P, postnatal day; MII, meiotic M-phase II.
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be the “guardian of meiotic recombination,” driving to apoptosis
any oocytes that fail to rejoin their chromosome arms on time.
These observations support the hypothesis that the original
role, in evolutionary terms, of TAp63 may be the protection of
the gene pool from meiotic recombination failure and not nec-
essarily from externally inﬂicted genotoxic insults. Therefore, the
deleterious role of TAp63 following exogenous genotoxic stress
might be an undesired remnant of a p63-related recombination
checkpoint.
At the moment, it remains unknown what processes take place
at the late pre-antral follicular stage that would lead to the disap-
pearance of TAp63 andTAp63-dependent apoptosis. Nevertheless,
it is a fact that a p63-dependent apoptotic mechanism is absent in
antral follicles. Therefore, an important question that arises is
how the non-apoptotic mature antral and pre-ovulatory follicles
(Figure 4) respond to oocyte DNA damage.
PROPHASE TO MI TRANSITION
From the antral and up to the pre-ovulatory follicle, the response
to DNA damage may involve the activation of repair mechanisms
alone. At these stages of follicular development, physiological
prophase arrest means that a DNA damage-induced checkpoint is
not required to halt the cell cycle in order to permit repair. How-
ever, the fully grown oocyte in the pre-ovulatory follicle would not
be expected to respond to DNA damage solely by repair mecha-
nisms, but also by cell cycle arrest checkpoints. At this stage, the
oocyte has reached full cytoplasmic and nuclear development and
has acquired the competence to enter meiotic M-phase as soon as
the LH surge occurs (Eppig, 1996). In the mouse, cell cycle regula-
tors that are important for M-phase entry, such as cyclin B, CDK1,
and Cdc25 accumulate in the fully grown, pre-ovulatory oocyte
(Kanatsu-Shinohara et al., 2000).
Considering the resemblance ofmeiotic prophase arrest and the
G2 DDC, it would be anticipated that fully grown oocytes employ
similar DDR mechanisms as the ones present in somatic cell G2
phase. Therefore, it is surprising that a DDC is not established in
response to DNA damage in M-phase competent oocytes.
Studies in mouse oocytes have shown that radiation-induced
DNA damage may cause chromosomal aberrations, such as aneu-
ploidy, translocations, chromatid interchanges and breaks (Tease,
1983; Jacquet et al., 2005). Past studies hinted at the possibility of a
limitedDDR in fully grownoocytes (Mailhes et al., 1994; Bradshaw
et al., 1995). More speciﬁcally, it has been shown that a signiﬁcant
delay in the duration of MI is not observed following injection
into female mice of etoposide, a topoisomerase II inhibitor and
DSB inducer (Mailhes et al., 1994; Bradshaw et al., 1995).
Recently, the fully grown oocyte DDR has been examined
in greater detail. In fully grown oocytes, DNA damage in the
form of DSBs, that would normally cause G2 arrest in somatic
cells, does not affect the timing and rate of entry into M-phase
(Marangos and Carroll, 2012). Although, a DDC is not being
established efﬁciently, DNA damage detection is effective. This
has been determined by the presence of γH2AX at the DSB sites.
A DDC is only established following very severe DNA damage
inﬂicted by high concentrations of Etoposide or the DNA interca-
lating agent Doxorubicin, causing a signiﬁcant delay in M-phase
entry (Marangos and Carroll, 2012). Similar observations were
also seen with the use of another DSB-inducing agent Neocarzi-
nostatin (Yuen et al., 2012). Nevertheless, even following severe
DNA damage and prolonged arrest, oocytes will eventually enter
M-phase. The failure to establish a DDC in prophase-arrested
oocytes could be attributed to checkpoint adaptation: a mecha-
nism, which in somatic cells, involves Polo-like kinase 1 (Plk1)
and Claspin and leads to the eventual inactivation of the G2
DDC in the presence of irreversible DNA damage (Yoo et al., 2004;
Syljuasen et al., 2006).
The molecular basis for the absence of a reliable DDC in
response to DSBs appears to be due to a limited ability to acti-
vate ATM kinase (Marangos and Carroll, 2012). The lack of ATM
activity also affects the activation levels of downstream effectors
such as Chk1. Low levels of expression of ATM in fully grown
oocytes could be the reason for limited ATM activity. Another
possibility could be the distinct chromatin conﬁguration in fully
grown oocytes (Marangos and Carroll, 2012). The fully grown
oocyte is subjected to chromatin histone modiﬁcations such as
deacetylation and methylation which are crucial for chromatin
condensation and transcriptionally inactive heterochromatin for-
mation (Mattson and Albertini, 1990; De La Fuente, 2006; Ma
et al., 2012). Considering that the DDR and ATM speciﬁcally
are known to be inﬂuenced by changes in chromatin structure
and chromatin condensation (Bakkenist and Kastan, 2003), one
hypothesis might be that DDR mechanisms are either not able
to engage or are not triggered due to the fully grown oocyte
specialized chromatin conﬁguration.
The inductionof Cdc25Adegradation andCdc25B inactivation
are also inhibited following DNA damage in fully grown oocytes.
The lack of Cdc25Adestruction appears to be independent of ATM
activity on account of the fact that Cdc25A is still present follow-
ing high levels of DNA damage when ATM and Chk1 are active.
However, the inability of DSBs to block Cdc25B activity seems
to be ATM/Chk1-dependent since high levels of DNA damage
cause a dramatic inhibitory phosphorylation of the phosphatase
(Marangos and Carroll, 2012). Cdc25B inactivation could explain
the sustained prophase arrest observed following signiﬁcant levels
of damage. This is not surprising considering that Cdc25B is irre-
placeable in oocytes and the absence of Cdc25B, as in Cdc25B null
mice, leads to female infertility due to the inability of oocytes to
enter M-phase (Ferguson et al., 2005).
Besides DSBs, another type of highly toxic DNA lesions, inter-
strand crosslinks (ICLs), do not appear to activate an efﬁcient
DDR. In fully grown mouse oocytes, a major ICL repair factor,
the Fanconi Anemia protein FANCD2 fails to be recruited to the
sites of the DNA lesions (Yuen et al., 2012). Therefore, ICLs are
not being repaired. Nevertheless, the oocytes enter M-phase with-
out any delay. An explanation for these observations could be the
possible absence of the activity of the ATM-related kinase, ATR.
In somatic cells, ATR and its downstream effector Chk1 become
active and enable a checkpoint in response to ICLs (Wang, 2007;
Ben-Yehoyada et al., 2009). ATR is also required for the efﬁcient
monoubiquitination of FANCD2 enabling its role as an ICL repair
factor (Andreassen et al., 2004). It would be interesting to see
whetherATR can become active in fully grown oocytes in response
to DNA damage. It is possible that, as in the case of ATM, ATR is
either not expressed or unable to become recruited to the oocyte
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chromatin. This could explain the absence of FANCD2 and the
subsequent inefﬁciency of the Fanconi Anemia pathway in fully
grown oocytes.
It is not yet clear why fully grown oocytes cannot activatemajor
DDR factors, such as ATM or repair factors, such as FANCD2.
Although we have provided some possible explanations, further
work is necessary in order to understand themechanisms involved.
Irrespective of how the system functions, it may be that oocytes
have the capacity to resolve DNA lesions later in the cell cycle,
perhaps during MI or MII, or even after fertilization during early
embryonic development.
MEIOTIC M-PHASE RESPONSE TO DNA DAMAGE
When a follicle reaches the pre-ovulatory stage it responds to the
surge of LH and as a result the fully grown oocyte exits prophase
arrest and enters MI. Resumption of meiosis leads to the ﬁrst mei-
otic division and the extrusion of the ﬁrst polar body (Pb1) which
contains half of the homologous chromosomes and a minimum
amount of cytoplasm. The oocyte then enters the secondM-phase
(MII) without an intervening interphase. It is at this stage the
oocyte is ovulated and fertilization takes place. Egg activation trig-
gers the completion of the second meiotic division and entry into
the ﬁrst embryonic cell cycle.
Considering the inability of meiotic prophase to establish a
DDC, the two meiotic M-phases pose the only possible line of
defense against DNA damage inﬂicted to the fully grown oocyte
before the damage reaches the developing embryo. However,
the knowledge on possible meiotic M-phase DDR mechanisms
is extremely limited. When fully grown oocytes are exposed to
the DSB-inducing agent Neocarzinostatin MI division is blocked
(Yuen et al., 2012). It is not yet known, however, how sensitive this
M-phase arrest is and which factors are implicated. Interestingly,
the presence of ICLs in either MI or MII does not inhibit or delay
cell division. However, ICLs formed in oocytes affect the quality
anddevelopment of the resulting pre-implantation embryos (Yuen
et al., 2012). Therefore, it seems that, the decision to establish or
not anM-phase DDC depends on the type of DNA damage. More
work needs to be done, in order to clarify the M-phase response
to DNA damage.
CONCLUDING REMARKS
The experimental evidence of especially the last decade has shed
light into the diverse ways by which the mammalian oocyte
responds to DNA damage. From our current knowledge we can
assume that a DDC is necessary, primarily, for avoiding mei-
otic recombination errors in order to ensure correct chromosome
segregation during the meiotic divisions. After birth, the TAp63-
dependent checkpoint appears to be dispensable. The absence of
apoptosis indamagedprimordial follicle oocytes is not detrimental
probably because the oocytes remain arrested at prophase where
they have the time to repair any inﬂicted DNA damage. However,
at the moment when a DDC is mostly needed, when the oocyte
acquires the competence to enterM-phase, cell cycle arrest mecha-
nisms thatwould respond toDNAdamage are absent. It seems that
the oocytes ﬁnd preferable for DNAdamage to be confronted later,
in M-phase or the early embryonic cell cycles. Nonetheless, many
important questions are still unanswered: is the recombination
DDC a p63-dependent apoptosis mechanism? Why does the fully
grown oocyte choose not to activate DDCs?Whatmechanisms are
recruited in meiotic M-phase to respond to DNA damage? There-
fore, there are still many pieces to be found in the puzzle that is
the DDR of mammalian oocytes.
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